
Interventional Cardiovascular Device Market is likely to expand US$ 2.5 Bn at 10.6% CAGR by 2032 -GE Healthcare, Boston Scientific, Philips, Volcano Therapeutics, Argon Medical, Spectranetics, Angio Dynamics, AccessClosure, Merit Medical Systems, B. Braun | openPR.com - New Public Relations: Business, Economy, Finances, Banking & Insurance
